Bruce T.

Bruce T. has an extensive work experience history starting in 2011 as a Senior Portfolio Manager at Lombard Odier Investment Managers. Bruce later held roles as Vice President at Ionis Pharmaceuticals, Inc., Expert Scientist and Vice President at Roche, and Managing Director at The Private Investment Group. More recently, Bruce has been involved in various leadership positions such as Founder and CEO of Xanadu Bio, Board Member and Founder at Gennao Bio, and Managing Partner at Madison Avenue Investors, LLC. Currently, they serve as Interim Chief Financial Officer and Chief Strategy Officer at MorphImmune, Co-Founder and Board Chairman at Talos Surgical, and Executive Vice President at Immunome, Inc.

Bruce T. completed their Bachelor of Arts in Biology at the University of Chicago from 1982 to 1986. Bruce then pursued a MD PhD in Immunology and Molecular Genetics at the University of Pennsylvania School of Medicine from 1986 to 1992. Finally, they completed an Oncology Residency and Post Doctoral Fellowship in Molecular Genetics at Yale University School of Medicine from 1995 to 1998.